MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 165 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $527,000 | +51.9% | 10,046 | -3.5% | 0.02% | +41.2% |
| Q2 2020 | $347,000 | +30.0% | 10,415 | +6.0% | 0.02% | +13.3% |
| Q1 2020 | $267,000 | +57.1% | 9,828 | +14.2% | 0.02% | +87.5% |
| Q4 2019 | $170,000 | +63.5% | 8,604 | +7.1% | 0.01% | +60.0% |
| Q3 2019 | $104,000 | +4.0% | 8,032 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $100,000 | -14.5% | 8,032 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $117,000 | +64.8% | 8,032 | +24.6% | 0.01% | +25.0% |
| Q4 2018 | $71,000 | -58.2% | 6,446 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $170,000 | +28.8% | 6,446 | 0.0% | 0.01% | +33.3% |
| Q2 2018 | $132,000 | +12.8% | 6,446 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $117,000 | +30.0% | 6,446 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $90,000 | -16.7% | 6,446 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $108,000 | -0.9% | 6,446 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $109,000 | +45.3% | 6,446 | +14.9% | 0.01% | +25.0% |
| Q1 2017 | $75,000 | – | 5,612 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |